You are here: Home » PTI Stories » National » News
Business Standard

Revision of essential drugs under NLEM ongoing process: Govt

Press Trust of India  |  New Delhi 

The revision of essential medicines under the National List of Medicines is an ongoing process, was informed today.

"The revision of the National List of Medicines (NLEM) by the Ministry of Health and Family Welfare is an ongoing process," Minister of Chemicals and Fertilisers Ananth Kumar said in a reply in the Rajya Sabha.



NLEM was first formulated in 1996. It was later revised in 2003 and 2011. The last revision was notified on December 23, 2015, he added.

"Some of the criteria for inclusion are that medicines should be approved/licensed in India, it should be useful to diseases which are a public health problem in and should have proven efficacy and safety profile," Kumar said.

The NLEM notified in December last year contains 376 medicines, which includes 59 for treatment of cancer, he added.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Revision of essential drugs under NLEM ongoing process: Govt

The revision of essential medicines under the National List of Medicines is an ongoing process, Parliament was informed today. "The revision of the National List of Medicines (NLEM) by the Ministry of Health and Family Welfare is an ongoing process," Minister of Chemicals and Fertilisers Ananth Kumar said in a reply in the Rajya Sabha. NLEM was first formulated in 1996. It was later revised in 2003 and 2011. The last revision was notified on December 23, 2015, he added. "Some of the criteria for inclusion are that medicines should be approved/licensed in India, it should be useful to diseases which are a public health problem in India and should have proven efficacy and safety profile," Kumar said. The NLEM notified in December last year contains 376 medicines, which includes 59 for treatment of cancer, he added. The revision of essential medicines under the National List of Medicines is an ongoing process, was informed today.

"The revision of the National List of Medicines (NLEM) by the Ministry of Health and Family Welfare is an ongoing process," Minister of Chemicals and Fertilisers Ananth Kumar said in a reply in the Rajya Sabha.

NLEM was first formulated in 1996. It was later revised in 2003 and 2011. The last revision was notified on December 23, 2015, he added.

"Some of the criteria for inclusion are that medicines should be approved/licensed in India, it should be useful to diseases which are a public health problem in and should have proven efficacy and safety profile," Kumar said.

The NLEM notified in December last year contains 376 medicines, which includes 59 for treatment of cancer, he added.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Revision of essential drugs under NLEM ongoing process: Govt

The revision of essential medicines under the National List of Medicines is an ongoing process, was informed today.

"The revision of the National List of Medicines (NLEM) by the Ministry of Health and Family Welfare is an ongoing process," Minister of Chemicals and Fertilisers Ananth Kumar said in a reply in the Rajya Sabha.

NLEM was first formulated in 1996. It was later revised in 2003 and 2011. The last revision was notified on December 23, 2015, he added.

"Some of the criteria for inclusion are that medicines should be approved/licensed in India, it should be useful to diseases which are a public health problem in and should have proven efficacy and safety profile," Kumar said.

The NLEM notified in December last year contains 376 medicines, which includes 59 for treatment of cancer, he added.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard